•  
  •  
  •  
  •  

2023-03-21 17:15:47

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • ICRA reaffirms rating of Acknit Industries Ltd
  • Faisal Islamic Bank, set to revolutionize Egypt's digital banking experience with Intellect Global Consumer Banking's CBX Platform
  • Thomas Cook India & SOTC Travel partner with LTIMindtree to launch 'Green Carpet'
  • NMDC Ltd announces price revision of Iron Ore from March 21, 2023
  • Zydus granted Orphan Drug Designation by the USFDA for ZYIL1 in treatment of patients with Cryopyrin Associated Periodic Syndrome

Keywords Selected:  AnchorInvestors

IPO News

  • Radiant Cash Management Services Ltd raises Rs 116 crore from anchor investors
  • Elin Electronics Ltd raises Rs 142 crs crore from 8 anchor investors
  • Dharmaj Crop Guard Ltd raises Rs 75 crore from anchor investors
  • Bikaji Foods International Ltd raises Rs 262 crore from anchor investors
  • Harsha Engineers International Ltd raises Rs 225.7 crore from anchor investors
  • eMudhra Ltd raises Rs 123.83 crore from anchor investors
  • Ethos Limited IPO opens for subscription
  • Ethos Ltd raises Rs 141.69 crore from 9 anchor investors
  • Data Patterns India raises Rs 176 crore from anchor investors ahead of IPO
  • Anand Rathi Wealth raises Rs. 193.87 crore from 12 anchor investors
  • Mining Player Tega Industries raises Rs 186 crore from 14 anchor investors
  • Aptus Value Housing Finance India Limited raises Rs. 834 crs from 21 Anchor Investors

Stock Report

  • Patanjali-backed Ruchi Soya raises Rs 1,290 crore from anchor investors

Latest Post

  • ICRA reaffirms rating of Acknit Industries Ltd
  • Faisal Islamic Bank, set to revolutionize Egypt's digital banking experience with Intellect Global Consumer Banking's CBX Platform
  • Thomas Cook India & SOTC Travel partner with LTIMindtree to launch 'Green Carpet'
  • NMDC Ltd announces price revision of Iron Ore from March 21, 2023
  • Zydus granted Orphan Drug Designation by the USFDA for ZYIL1 in treatment of patients with Cryopyrin Associated Periodic Syndrome


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2022